Drugs Made In America Acquisition II LLC bought DMII
September 26, 2025 · Form 4 insider transaction
Drugs Made In America Acquisition II LLC bought 700,000 shares of Drugs Made In America Acquisition II Corp., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
700,000
Price
N/A
Total value
N/A
Role—
SecurityOrdinary shares
Transaction codeP: Open-market purchase
Transaction dateSeptember 26, 2025
Filing dateOctober 1, 2025
Shares owned after15,075,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects 700,000 private units acquired by the reporting person, the Issuer's sponsor. Each private unit consists of one ordinary share and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of an initial business combination. The private units were purchased at $10 per unit for an aggregate purchase price of $7,000,000.